Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
39.93B | 36.99B | 29.05B | 34.16B | 35.36B | 36.75B | Gross Profit |
8.01B | 7.60B | 5.59B | 6.41B | 6.64B | 6.93B | EBIT |
3.02B | 2.80B | 965.75M | 1.93B | 2.38B | 2.65B | EBITDA |
3.75B | 4.51B | 2.80B | 3.48B | 3.15B | 3.50B | Net Income Common Stockholders |
2.32B | 2.06B | 1.27B | 1.81B | 1.62B | 1.94B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
9.13B | 17.01B | 14.68B | 11.88B | 11.77B | 11.26B | Total Assets |
40.73B | 44.77B | 38.72B | 38.79B | 39.11B | 37.55B | Total Debt |
0.00 | 170.78M | 153.24M | 213.09M | 134.25M | 124.59M | Net Debt |
-9.13B | -16.84B | -14.53B | -11.67B | -11.64B | -10.01B | Total Liabilities |
8.86B | 13.75B | 10.76B | 11.23B | 13.11B | 13.15B | Stockholders Equity |
31.26B | 30.29B | 27.29B | 26.96B | 25.44B | 23.82B |
Cash Flow | Free Cash Flow | ||||
0.00 | 2.66B | 2.94B | 894.26M | 1.52B | 2.53B | Operating Cash Flow |
0.00 | 3.62B | 4.34B | 2.11B | 2.11B | 3.23B | Investing Cash Flow |
0.00 | -874.11M | -774.84M | -1.32B | -714.19M | -974.00M | Financing Cash Flow |
0.00 | -621.26M | -958.39M | -691.19M | -604.49M | -635.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥24.20B | 7.05 | 6.51% | 0.36% | 242.74% | ||
74 Outperform | ¥15.77B | 7.21 | 3.64% | -5.40% | ― | ||
72 Outperform | ¥16.89B | 6.89 | 6.03% | 8.72% | 16.58% | ||
68 Neutral | ¥21.72B | 29.19 | 4.66% | 1.74% | -82.49% | ||
63 Neutral | $6.98B | 11.41 | 2.80% | 4.24% | 2.68% | -24.94% | |
52 Neutral | ¥17.90B | ― | 3.24% | 0.66% | -340.28% | ||
48 Neutral | ¥21.23B | ― | 3.62% | -1.68% | -240.66% |